<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-05-26 14:17</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>31802391</mtid>
      <status>APPROVED</status>
      <published>true</published>
      <comment>Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands            
            Rheumatology, University of Debrecen, Debrecen, Hungary            
            Rheumatology, Bacs-Kiskun Megyei Korhaz, Kecskemet, Hungary            
            Genetics Cell- and Immunobiology and Rheumatology and Clinical Rheumatology, Semmelweis University, Budapest, Hungary            
            Rheumatology, Leiden University Medical Center, Leiden, Netherlands            
            Cited By :45            
            Export Date: 22 June 2024            
            Correspondence Address: Roodenrijs, N.M.T.; Rheumatology and Clinical Immunology, Netherlands; email: n.m.t.roodenrijs@umcutrecht.nl            
            Chemicals/CAS: abatacept, 332348-12-6; adalimumab, 331731-18-1, 1446410-95-2; azathioprine, 446-86-6; baricitinib, 1187594-09-7; C reactive protein, 9007-41-4; certolizumab pegol, 428863-50-7; cyclosporine, 59865-13-3, 63798-73-2, 79217-60-0; etanercept, 185243-69-0, 200013-86-1, 2055118-96-0; filgotinib, 1206161-97-8, 1540859-07-1, 1802998-75-9; golimumab, 476181-74-5; infliximab, 170277-31-3; ixekizumab, 1143503-69-8; mavrilimumab, 1085337-57-0; methotrexate, 15475-56-6, 59-05-2, 7413-34-5, 7532-09-4, 6745-93-3; ocrelizumab, 637334-45-3; olokizumab, 1007223-17-7; rituximab, 174722-31-7; salazosulfapyridine, 599-79-1; sarilumab, 1189541-98-7; secukinumab, 875356-43-7, 875356-44-8; sirukumab, 1194585-53-9; tacrolimus, 104987-11-3; tocilizumab, 375823-41-9; tofacitinib, 477600-75-2, 540737-29-9; upadacitinib, 1310726-60-3, 1607431-21-9; Antirheumatic Agents; Biological Products; Tumor Necrosis Factor-alpha</comment>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-05-20T12:18:04.853+0000</lastRefresh>
      <lastModified>2025-07-30T08:20:55.910+0000</lastModified>
      <created>2021-01-08T18:27:05.438+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10015206</mtid>
        <familyName>Áncsán</familyName>
        <givenName>Gizella</givenName>
        <link>/api/admin/10015206</link>
        <otype>Admin</otype>
        <label>Áncsán Gizella (SE admin)</label>
        <published>true</published>
        <oldId>10015206</oldId>
      </creator>
      <lastDuplumOK>2025-07-30T09:12:57.915+0000</lastDuplumOK>
      <lastDuplumSearch>2025-07-30T09:12:57.915+0000</lastDuplumSearch>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>1134514</mtid>
        <nameEng>Survey paper</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/1134514</link>
        <name>Összefoglaló cikk</name>
        <otype>SubType</otype>
        <label>Összefoglaló cikk (Folyóiratcikk)</label>
        <listPosition>102</listPosition>
        <published>true</published>
        <oldId>1134514</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Roodenrijs, Nadia M T</firstAuthor>
      <title>Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/10055729</link>
        <reviewType>REVIEWED</reviewType>
        <label>RMD OPEN 2056-5933 2056-5933</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>10055729</oldId>
        <noIF>false</noIF>
        <mtid>10055729</mtid>
        <scopusIndexed>true</scopusIndexed>
        <pIssn>2056-5933</pIssn>
        <eIssn>2056-5933</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>7</volume>
      <issue>1</issue>
      <internalId>e001512</internalId>
      <firstPageOrInternalIdForSort>e001512</firstPageOrInternalIdForSort>
      <pageLength>20</pageLength>
      <publishedYear>2021</publishedYear>
      <digital>true</digital>
      <printed>true</printed>
      <sourceYear>2021</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-05-20</oaCheckDate>
      <oaFree>true</oaFree>
      <oaLink>https://doi.org/10.1136/rmdopen-2020-001512</oaLink>
      <citationCount>100</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>99</citationCountWoOther>
      <independentCitCountWoOther>92</independentCitCountWoOther>
      <nationalOriginCitationCount>6</nationalOriginCitationCount>
      <foreignEditionCitationCount>99</foreignEditionCitationCount>
      <doiCitationCount>95</doiCitationCount>
      <wosCitationCount>83</wosCitationCount>
      <scopusCitationCount>86</scopusCitationCount>
      <wosScopusCitationCount>98</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>98</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>91</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>91</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>93</independentCitationCount>
      <selfCitationCount>7</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>100</citingPubCount>
      <independentCitingPubCount>93</independentCitingPubCount>
      <citingPubCountWoOther>99</citingPubCountWoOther>
      <independentCitingPubCountWoOther>92</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>3</citedPubCount>
      <citedCount>3</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>98</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>1</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>1</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2021</year>
          <publicationCount>0</publicationCount>
          <citationCount>6</citationCount>
          <independentCitationCount>4</independentCitationCount>
          <citingPubCount>6</citingPubCount>
          <independentCitingPubCount>4</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2022</year>
          <publicationCount>0</publicationCount>
          <citationCount>19</citationCount>
          <independentCitationCount>17</independentCitationCount>
          <citingPubCount>19</citingPubCount>
          <independentCitingPubCount>17</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2023</year>
          <publicationCount>0</publicationCount>
          <citationCount>18</citationCount>
          <independentCitationCount>18</independentCitationCount>
          <citingPubCount>18</citingPubCount>
          <independentCitingPubCount>18</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2024</year>
          <publicationCount>0</publicationCount>
          <citationCount>23</citationCount>
          <independentCitationCount>23</independentCitationCount>
          <citingPubCount>23</citingPubCount>
          <independentCitingPubCount>23</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>25</citationCount>
          <independentCitationCount>24</independentCitationCount>
          <citingPubCount>25</citingPubCount>
          <independentCitingPubCount>24</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>9</citationCount>
          <independentCitationCount>7</independentCitationCount>
          <citingPubCount>9</citingPubCount>
          <independentCitingPubCount>7</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>D1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2021-01-07T18:27:33.983+0000</userChangeableUntil>
      <directInstitutesForSort>Genetikai, Sejt- és Immunbiológiai Intézet (SE / AOK / I); Reumatológiai Tanszék (DE / ÁOK / BelgyI); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK)</directInstitutesForSort>
      <ownerAuthorCount>3</ownerAuthorCount>
      <ownerInstituteCount>24</ownerInstituteCount>
      <directInstituteCount>3</directInstituteCount>
      <authorCount>7</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020359</mtid>
          <link>/api/authorship/95020359</link>
          <label>Roodenrijs, Nadia M T ✉</label>
          <listPosition>1</listPosition>
          <share>0.14285715</share>
          <first>true</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <familyName>Roodenrijs</familyName>
          <givenName>Nadia M T</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020360</mtid>
          <link>/api/authorship/95020360</link>
          <label>Hamar, Attila [Hamar, Attila (általános orvos), szerző] Reumatológiai Tanszék (DE / ÁOK / BelgyI)</label>
          <listPosition>2</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10057639</mtid>
            <link>/api/author/10057639</link>
            <label>Hamar Attila (általános orvos)</label>
            <familyName>Hamar</familyName>
            <givenName>Attila</givenName>
            <published>true</published>
            <oldId>10057639</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Hamar</familyName>
          <givenName>Attila</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020361</mtid>
          <link>/api/authorship/95020361</link>
          <label>Kedves, Melinda [Kedves, Melinda (Reumatológia), szerző]</label>
          <listPosition>3</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10094727</mtid>
            <link>/api/author/10094727</link>
            <label>Kedves Melinda (Reumatológia)</label>
            <familyName>Kedves</familyName>
            <givenName>Melinda</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Kedves</familyName>
          <givenName>Melinda</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020362</mtid>
          <link>/api/authorship/95020362</link>
          <label>Nagy, György [Nagy, György (Immunológia), szerző] Genetikai, Sejt- és Immunbiológiai Intézet (SE / AOK / I); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK)</label>
          <listPosition>4</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10025749</mtid>
            <link>/api/author/10025749</link>
            <label>Nagy György (Immunológia)</label>
            <familyName>Nagy</familyName>
            <givenName>György</givenName>
            <published>true</published>
            <oldId>10025749</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Nagy</familyName>
          <givenName>György</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020363</mtid>
          <link>/api/authorship/95020363</link>
          <label>van Laar, Jacob M</label>
          <listPosition>5</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>van Laar</familyName>
          <givenName>Jacob M</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020364</mtid>
          <link>/api/authorship/95020364</link>
          <label>van der Heijde, Désirée</label>
          <listPosition>6</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>van der Heijde</familyName>
          <givenName>Désirée</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>95020365</mtid>
          <link>/api/authorship/95020365</link>
          <label>Welsing, Paco M J</label>
          <listPosition>7</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>true</last>
          <corresponding>false</corresponding>
          <familyName>Welsing</familyName>
          <givenName>Paco M J</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>18278281</mtid>
          <link>/api/publicationidentifier/18278281</link>
          <label>DOI: 10.1136/rmdopen-2020-001512</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <validState>IDENTICAL</validState>
          <idValue>10.1136/rmdopen-2020-001512</idValue>
          <realUrl>https://doi.org/10.1136/rmdopen-2020-001512</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>18351458</mtid>
          <link>/api/publicationidentifier/18351458</link>
          <label>WoS: 000606022300001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>000606022300001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/000606022300001</realUrl>
          <published>true</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>18345525</mtid>
          <link>/api/publicationidentifier/18345525</link>
          <label>Scopus: 85099202959</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>85099202959</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85099202959</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>18345526</mtid>
          <link>/api/publicationidentifier/18345526</link>
          <label>PubMed: 33419871</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>33419871</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=33419871&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>20368875</mtid>
          <link>/api/publicationidentifier/20368875</link>
          <label>Egyéb URL: https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>40</mtid>
            <link>/api/publicationsource/40</link>
            <label>Egyéb URL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10006</mtid>
              <link>/api/publicationsourcetype/10006</link>
              <label>Link</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Egyéb URL</name>
            <nameEng>Other URL</nameEng>
            <linkPattern>@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>40</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>NONE</oaType>
          <validState>IDENTICAL</validState>
          <idValue>https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512</idValue>
          <realUrl>https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <subjects>
        <classification>
          <otype>Classification</otype>
          <mtid>12215</mtid>
          <link>/api/classification/12215</link>
          <label>Klinikai orvostan</label>
          <published>true</published>
          <snippet>true</snippet>
        </classification>
      </subjects>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11235242</mtid>
          <link>/api/sjrrating/11235242</link>
          <label>sjr:D1 (2021) Scopus - Rheumatology RMD OPEN 2056-5933</label>
          <listPos>6</listPos>
          <rankValue>0.1</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>2745</mtid>
            <link>/api/classificationexternal/2745</link>
            <label>Scopus - Rheumatology</label>
            <published>true</published>
            <oldId>2745</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>D1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>2880208</mtid>
          <link>/api/reference/2880208</link>
          <label>1. , DOI: 10.1136/annrheumdis-2019-216655</label>
          <listPosition>1</listPosition>
          <doi>10.1136/annrheumdis-2019-216655</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880209</mtid>
          <link>/api/reference/2880209</link>
          <label>2. Singh 2015: American College of rheumatology guideline for the treatment of rheumatoid arthritis, Arthritis Rheumatol, 2016, p. 1</label>
          <listPosition>2</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880210</mtid>
          <link>/api/reference/2880210</link>
          <label>3. , DOI: 10.1136/annrheumdis-2017-212862</label>
          <listPosition>3</listPosition>
          <doi>10.1136/annrheumdis-2017-212862</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880211</mtid>
          <link>/api/reference/2880211</link>
          <label>4. de Hair 2017: Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need, Rheumatology, 57, p. 1135</label>
          <listPosition>4</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880212</mtid>
          <link>/api/reference/2880212</link>
          <label>5. , DOI: 10.1136/annrheumdis-2018-213378</label>
          <listPosition>5</listPosition>
          <doi>10.1136/annrheumdis-2018-213378</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880213</mtid>
          <link>/api/reference/2880213</link>
          <label>6. Nagy G , Roodenrijs NMT , Welsing PMJ . EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 2020:annrheumdis-2020-217344., DOI: 10.1136/annrheumdis-2020-219535</label>
          <listPosition>6</listPosition>
          <doi>10.1136/annrheumdis-2020-219535</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880214</mtid>
          <link>/api/reference/2880214</link>
          <label>7. , DOI: 10.1136/annrheumdis-2018-213687</label>
          <listPosition>7</listPosition>
          <doi>10.1136/annrheumdis-2018-213687</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880215</mtid>
          <link>/api/reference/2880215</link>
          <label>8. Roodenrijs NMT , de Hair MJH , van der Goes MC , et al . Correspondence to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch. Ann Rheum Dis 2019;78:e105. doi:10.1136/annrheumdis-2018-214147, DOI: 10.1136/annrheumdis-2018-214147</label>
          <listPosition>8</listPosition>
          <doi>10.1136/annrheumdis-2018-214147</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880216</mtid>
          <link>/api/reference/2880216</link>
          <label>9. Roodenrijs 2020: Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease, Rheumatology, DOI: 10.1093/rheumatology/keaa860</label>
          <listPosition>9</listPosition>
          <doi>10.1093/rheumatology/keaa860</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880217</mtid>
          <link>/api/reference/2880217</link>
          <label>10. , DOI: 10.3899/jrheum.140976</label>
          <listPosition>10</listPosition>
          <doi>10.3899/jrheum.140976</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880218</mtid>
          <link>/api/reference/2880218</link>
          <label>11. Roodenrijs NMT , Kedves M , Hamar A . Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review Informing the 2020 EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. Manuscript under review.</label>
          <listPosition>11</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880219</mtid>
          <link>/api/reference/2880219</link>
          <label>12. van der Heijde 2014: Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations, Ann Rheum Dis, 2015, p. 8</label>
          <listPosition>12</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880220</mtid>
          <link>/api/reference/2880220</link>
          <label>13. Thompson M , Tiwari A , Fu R . A framework to facilitate the use of systematic reviews and meta-analyses in the design of primary research studies. Rockville, MD agency Healthc. Res. Qual 2012 http://www.ncbi.nlm.nih.gov/books/ NBK83621/ (accessed 13 Nov 2019).</label>
          <listPosition>13</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880221</mtid>
          <link>/api/reference/2880221</link>
          <label>14. Higgins JPT , Altman DG , Gøtzsche PC , et al . The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. doi:10.1136/bmj.d5928, DOI: 10.1136/bmj.d5928</label>
          <listPosition>14</listPosition>
          <doi>10.1136/bmj.d5928</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880222</mtid>
          <link>/api/reference/2880222</link>
          <label>15. , DOI: 10.1059/0003-4819-155-8-201110180-00009</label>
          <listPosition>15</listPosition>
          <doi>10.1059/0003-4819-155-8-201110180-00009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880223</mtid>
          <link>/api/reference/2880223</link>
          <label>16. , DOI: 10.1136/bmj.j4008</label>
          <listPosition>16</listPosition>
          <doi>10.1136/bmj.j4008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880224</mtid>
          <link>/api/reference/2880224</link>
          <label>17. Abramkin 2017: THU0127 the dynamics of mental disorders frequency in complex dmards, biologics and antidepressants treatment of rheumatoid arthritis patients, Ann Rheum Dis, 76, p. :249.1</label>
          <listPosition>17</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880225</mtid>
          <link>/api/reference/2880225</link>
          <label>18. , DOI: 10.1093/rheumatology/ker190</label>
          <listPosition>18</listPosition>
          <doi>10.1093/rheumatology/ker190</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880226</mtid>
          <link>/api/reference/2880226</link>
          <label>19. Burmester 2017: SAT0202 efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy in patients with active rheumatoid arthritis in the phase 3 monarch study, including subpopulations, Ann Rheum Dis, 76, p. 849.1, DOI: 10.1136/annrheumdis-2016-210310</label>
          <listPosition>19</listPosition>
          <doi>10.1136/annrheumdis-2016-210310</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880227</mtid>
          <link>/api/reference/2880227</link>
          <label>20. Cantini 2014: HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-α) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis, Int J Rheumatol, 2014, p. 1, DOI: 10.1155/2014/926836</label>
          <listPosition>20</listPosition>
          <doi>10.1155/2014/926836</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880228</mtid>
          <link>/api/reference/2880228</link>
          <label>21. , DOI: 10.1136/annrheumdis-2014-206711</label>
          <listPosition>21</listPosition>
          <doi>10.1136/annrheumdis-2014-206711</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880229</mtid>
          <link>/api/reference/2880229</link>
          <label>22. Chen 2017: Short-Course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation, Int J Rheum Dis, 20, p. 859, DOI: 10.1111/1756-185X.13010</label>
          <listPosition>22</listPosition>
          <doi>10.1111/1756-185X.13010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880230</mtid>
          <link>/api/reference/2880230</link>
          <label>23. Clowse 2016: Pregnancy outcomes in the tofacitinib safety databases for rheumatoid arthritis and psoriasis, Drug Saf, 39, p. 755, DOI: 10.1007/s40264-016-0431-z</label>
          <listPosition>23</listPosition>
          <doi>10.1007/s40264-016-0431-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880231</mtid>
          <link>/api/reference/2880231</link>
          <label>24. , DOI: 10.1136/annrheumdis-2018-214261</label>
          <listPosition>24</listPosition>
          <doi>10.1136/annrheumdis-2018-214261</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880232</mtid>
          <link>/api/reference/2880232</link>
          <label>25. Deodhar 2016: The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis, Clin Rheumatol, 35, p. 3045, DOI: 10.1007/s10067-016-3422-7</label>
          <listPosition>25</listPosition>
          <doi>10.1007/s10067-016-3422-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880233</mtid>
          <link>/api/reference/2880233</link>
          <label>26. , DOI: 10.1136/annrheumdis-2019-eular.3110</label>
          <listPosition>26</listPosition>
          <doi>10.1136/annrheumdis-2019-eular.3110</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880234</mtid>
          <link>/api/reference/2880234</link>
          <label>27. , DOI: 10.1136/annrheumdis-2015-208840</label>
          <listPosition>27</listPosition>
          <doi>10.1136/annrheumdis-2015-208840</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880235</mtid>
          <link>/api/reference/2880235</link>
          <label>28. , DOI: 10.1002/acr.21768</label>
          <listPosition>28</listPosition>
          <doi>10.1002/acr.21768</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880236</mtid>
          <link>/api/reference/2880236</link>
          <label>29. Hang Y , Qin X , Ren T , et al . Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids Health Dis 2018;17:146. doi:10.1186/s12944-018-0797-2, DOI: 10.1186/s12944-018-0797-2</label>
          <listPosition>29</listPosition>
          <doi>10.1186/s12944-018-0797-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880237</mtid>
          <link>/api/reference/2880237</link>
          <label>30. , DOI: 10.1016/j.semarthrit.2016.05.004</label>
          <listPosition>30</listPosition>
          <doi>10.1016/j.semarthrit.2016.05.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880238</mtid>
          <link>/api/reference/2880238</link>
          <label>31. , DOI: 10.3899/jrheum.130658</label>
          <listPosition>31</listPosition>
          <doi>10.3899/jrheum.130658</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880239</mtid>
          <link>/api/reference/2880239</link>
          <label>32. Ikonomidis 2014: Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis, Circulation, 7, p. 619</label>
          <listPosition>32</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880240</mtid>
          <link>/api/reference/2880240</link>
          <label>33. , DOI: 10.1002/art.30136</label>
          <listPosition>33</listPosition>
          <doi>10.1002/art.30136</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880241</mtid>
          <link>/api/reference/2880241</link>
          <label>34. Lin 2015: Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study, Clin Rheumatol, 34, p. 1039, DOI: 10.1007/s10067-015-2962-6</label>
          <listPosition>34</listPosition>
          <doi>10.1007/s10067-015-2962-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880242</mtid>
          <link>/api/reference/2880242</link>
          <label>35. , DOI: 10.1136/annrheumdis-2014-206695</label>
          <listPosition>35</listPosition>
          <doi>10.1136/annrheumdis-2014-206695</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880243</mtid>
          <link>/api/reference/2880243</link>
          <label>36. Mouyis 2019: Safety of anti-rheumatic drugs in men trying to conceive: a systematic review and analysis of published evidence, Semin Arthritis Rheum, 48, p. 911, DOI: 10.1016/j.semarthrit.2018.07.011</label>
          <listPosition>36</listPosition>
          <doi>10.1016/j.semarthrit.2018.07.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880244</mtid>
          <link>/api/reference/2880244</link>
          <label>37. , DOI: 10.1093/rheumatology/kes190</label>
          <listPosition>37</listPosition>
          <doi>10.1093/rheumatology/kes190</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880245</mtid>
          <link>/api/reference/2880245</link>
          <label>38. Nakamura Y , Suzuki T , Yoshida T , et al . Vitamin D and calcium are required during denosumab treatment in osteoporosis with rheumatoid arthritis. Nutrients 2017;9:E428. doi:10.3390/nu9050428, DOI: 10.3390/nu9050428</label>
          <listPosition>38</listPosition>
          <doi>10.3390/nu9050428</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880246</mtid>
          <link>/api/reference/2880246</link>
          <label>39. Padovan 2016: Safety of abatacept in rheumatoid arthritis with serologic evidence of past or present hepatitis B virus infection, Arthritis Care Res, 68, p. 738, DOI: 10.1002/acr.22786</label>
          <listPosition>39</listPosition>
          <doi>10.1002/acr.22786</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880247</mtid>
          <link>/api/reference/2880247</link>
          <label>40. Papalopoulos 2018: Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study, Clin Exp Rheumatol, 36, p. 102</label>
          <listPosition>40</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880248</mtid>
          <link>/api/reference/2880248</link>
          <label>41. Ruscitti P , Masedu F , Alvaro S , et al . Anti-Interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (track): a multicentre, open-label, randomised controlled trial. PLoS Med 2019;16:e1002901. doi:10.1371/journal.pmed.1002901, DOI: 10.1371/journal.pmed.1002901</label>
          <listPosition>41</listPosition>
          <doi>10.1371/journal.pmed.1002901</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880249</mtid>
          <link>/api/reference/2880249</link>
          <label>42. Sammaritano LR , Bermas BL , Chakravarty EE . American College of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 2020;2020., DOI: 10.1002/art.41191</label>
          <listPosition>42</listPosition>
          <doi>10.1002/art.41191</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880250</mtid>
          <link>/api/reference/2880250</link>
          <label>43. Sepriano A , Kerschbaumer A , Smolen JS , et al . Safety of synthetic and biological DMARDs: a systematic literature review Informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2020:annrheumdis-2019-216653. doi:10.1136/annrheumdis-2019-216653, DOI: 10.1136/annrheumdis-2019-216653</label>
          <listPosition>43</listPosition>
          <doi>10.1136/annrheumdis-2019-216653</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880251</mtid>
          <link>/api/reference/2880251</link>
          <label>44. Shin 2017: Monthly oral ibandronate reduces bone loss in Korean women with rheumatoid arthritis and osteopenia receiving long-term glucocorticoids: a 48-week double-blinded randomized placebo-controlled investigator-initiated trial, Clin Ther, 39, p. 268, DOI: 10.1016/j.clinthera.2017.01.008</label>
          <listPosition>44</listPosition>
          <doi>10.1016/j.clinthera.2017.01.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880252</mtid>
          <link>/api/reference/2880252</link>
          <label>45. Strand 2018: SAT0207 depressive symptoms in patients with rheumatoid arthritis in sarilumab target and mobility trials and impact of treatment, Ann Rheum Dis, 77, p. 964.1</label>
          <listPosition>45</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880253</mtid>
          <link>/api/reference/2880253</link>
          <label>46. Suissa 2019: Comparative safety of abatacept in rheumatoid arthritis with COPD: a real-world population-based observational study, Semin Arthritis Rheum, 49, p. 366, DOI: 10.1016/j.semarthrit.2019.03.007</label>
          <listPosition>46</listPosition>
          <doi>10.1016/j.semarthrit.2019.03.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880254</mtid>
          <link>/api/reference/2880254</link>
          <label>47. , DOI: 10.1002/art.22070</label>
          <listPosition>47</listPosition>
          <doi>10.1002/art.22070</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880255</mtid>
          <link>/api/reference/2880255</link>
          <label>48. Yoo D-H , Park W , Suh C-H . Rituximab is effective in the treatment of rheumatoid arthritis irrespective of body mass index; up to 48 weeks results from phase 3 study. Arthritis Rheumatol 2017;69., DOI: 10.1136/annrheumdis-2017-eular.5591</label>
          <listPosition>48</listPosition>
          <doi>10.1136/annrheumdis-2017-eular.5591</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880256</mtid>
          <link>/api/reference/2880256</link>
          <label>49. Akiyama 2016: Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis, Clin Rheumatol, 35, p. 2829, DOI: 10.1007/s10067-016-3227-8</label>
          <listPosition>49</listPosition>
          <doi>10.1007/s10067-016-3227-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880257</mtid>
          <link>/api/reference/2880257</link>
          <label>50. Aletaha 2017: Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study, The Lancet, 389, p. 1206, DOI: 10.1016/S0140-6736(17)30401-4</label>
          <listPosition>50</listPosition>
          <doi>10.1016/S0140-6736(17)30401-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880258</mtid>
          <link>/api/reference/2880258</link>
          <label>51. Al-Gareeb 2018: Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study, Clin Rheumatol, 37, p. 2633, DOI: 10.1007/s10067-018-4164-5</label>
          <listPosition>51</listPosition>
          <doi>10.1007/s10067-018-4164-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880259</mtid>
          <link>/api/reference/2880259</link>
          <label>52. , DOI: 10.1186/ar2848</label>
          <listPosition>52</listPosition>
          <doi>10.1186/ar2848</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880260</mtid>
          <link>/api/reference/2880260</link>
          <label>53. , DOI: 10.3899/jrheum.101324</label>
          <listPosition>53</listPosition>
          <doi>10.3899/jrheum.101324</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880261</mtid>
          <link>/api/reference/2880261</link>
          <label>54. , DOI: 10.3310/hta22440</label>
          <listPosition>54</listPosition>
          <doi>10.3310/hta22440</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880262</mtid>
          <link>/api/reference/2880262</link>
          <label>55. Burmester 2013: Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial, The Lancet, 381, p. 451, DOI: 10.1016/S0140-6736(12)61424-X</label>
          <listPosition>55</listPosition>
          <doi>10.1016/S0140-6736(12)61424-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880263</mtid>
          <link>/api/reference/2880263</link>
          <label>56. , DOI: 10.1136/annrheumdis-2014-207178</label>
          <listPosition>56</listPosition>
          <doi>10.1136/annrheumdis-2014-207178</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880264</mtid>
          <link>/api/reference/2880264</link>
          <label>57. Charles-Schoeman 2017: THU0185 comparison of tofacitinib safety and efficacy in rheumatoid arthritis patients with inadequate response to conventional synthetic dmards, or to one or more biological dmards, Ann Rheum Dis, 76, p. 271.3</label>
          <listPosition>57</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880265</mtid>
          <link>/api/reference/2880265</link>
          <label>58. , DOI: 10.1136/annrheumdis-2013-204714</label>
          <listPosition>58</listPosition>
          <doi>10.1136/annrheumdis-2013-204714</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880266</mtid>
          <link>/api/reference/2880266</link>
          <label>59. , DOI: 10.3109/03009742.2012.729607</label>
          <listPosition>59</listPosition>
          <doi>10.3109/03009742.2012.729607</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880267</mtid>
          <link>/api/reference/2880267</link>
          <label>60. Cohen 2015: The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis, Clin Exp Rheumatol, 23, p. 795</label>
          <listPosition>60</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880268</mtid>
          <link>/api/reference/2880268</link>
          <label>61. , DOI: 10.1136/annrheumdis-2019-eular.4469</label>
          <listPosition>61</listPosition>
          <doi>10.1136/annrheumdis-2019-eular.4469</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880269</mtid>
          <link>/api/reference/2880269</link>
          <label>62. , DOI: 10.1136/annrheumdis-2013-204417</label>
          <listPosition>62</listPosition>
          <doi>10.1136/annrheumdis-2013-204417</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880270</mtid>
          <link>/api/reference/2880270</link>
          <label>63. Elmedany 2019: Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis, Clin Rheumatol, 38, p. 2109, DOI: 10.1007/s10067-019-04508-2</label>
          <listPosition>63</listPosition>
          <doi>10.1007/s10067-019-04508-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880271</mtid>
          <link>/api/reference/2880271</link>
          <label>64. , DOI: 10.1136/ard.2008.092932</label>
          <listPosition>64</listPosition>
          <doi>10.1136/ard.2008.092932</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880272</mtid>
          <link>/api/reference/2880272</link>
          <label>65. , DOI: 10.1136/annrheumdis-2013-203993</label>
          <listPosition>65</listPosition>
          <doi>10.1136/annrheumdis-2013-203993</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880273</mtid>
          <link>/api/reference/2880273</link>
          <label>66. , DOI: 10.1136/ard.2008.105064</label>
          <listPosition>66</listPosition>
          <doi>10.1136/ard.2008.105064</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880274</mtid>
          <link>/api/reference/2880274</link>
          <label>67. , DOI: 10.1056/NEJMoa1109071</label>
          <listPosition>67</listPosition>
          <doi>10.1056/NEJMoa1109071</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880275</mtid>
          <link>/api/reference/2880275</link>
          <label>68. Fleischmann 2017: Sarilumab and Nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors, Arthritis Rheumatol, 69, p. 277, DOI: 10.1002/art.39944</label>
          <listPosition>68</listPosition>
          <doi>10.1002/art.39944</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880276</mtid>
          <link>/api/reference/2880276</link>
          <label>69. , DOI: 10.1136/annrheumdis-2019-eular.2281</label>
          <listPosition>69</listPosition>
          <doi>10.1136/annrheumdis-2019-eular.2281</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880277</mtid>
          <link>/api/reference/2880277</link>
          <label>70. , DOI: 10.1002/art.30114</label>
          <listPosition>70</listPosition>
          <doi>10.1002/art.30114</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880278</mtid>
          <link>/api/reference/2880278</link>
          <label>71. , DOI: 10.1002/art.30373</label>
          <listPosition>71</listPosition>
          <doi>10.1002/art.30373</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880279</mtid>
          <link>/api/reference/2880279</link>
          <label>72. , DOI: 10.1136/annrheumdis-2012-202775</label>
          <listPosition>72</listPosition>
          <doi>10.1136/annrheumdis-2012-202775</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880280</mtid>
          <link>/api/reference/2880280</link>
          <label>73. Genovese 2014: A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors, Arthritis Rheumatol, 66, p. 1693, DOI: 10.1002/art.38617</label>
          <listPosition>73</listPosition>
          <doi>10.1002/art.38617</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880281</mtid>
          <link>/api/reference/2880281</link>
          <label>74. , DOI: 10.3899/jrheum.140238</label>
          <listPosition>74</listPosition>
          <doi>10.3899/jrheum.140238</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880282</mtid>
          <link>/api/reference/2880282</link>
          <label>75. , DOI: 10.1136/annrheumdis-2013-204760</label>
          <listPosition>75</listPosition>
          <doi>10.1136/annrheumdis-2013-204760</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880283</mtid>
          <link>/api/reference/2880283</link>
          <label>76. Genovese 2016: Baricitinib in patients with refractory rheumatoid arthritis, N Engl J Med Overseas Ed, 374, p. 1243, DOI: 10.1056/NEJMoa1507247</label>
          <listPosition>76</listPosition>
          <doi>10.1056/NEJMoa1507247</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880284</mtid>
          <link>/api/reference/2880284</link>
          <label>77. Genovese 2017: Improvements in Remission and Low Disease Activity Are Achieved with Ongoing Sarilumab Treatment, in Patients with Rheumatoid Arthritis in 2 Phase 3 Studies - ACR Meeting Abstracts, Arthritis Rheumatol, 69, p. Suppl 10</label>
          <listPosition>77</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880285</mtid>
          <link>/api/reference/2880285</link>
          <label>78. Genovese 2018: Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis, Rheumatology, 57, p. 900, DOI: 10.1093/rheumatology/kex489</label>
          <listPosition>78</listPosition>
          <doi>10.1093/rheumatology/kex489</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880286</mtid>
          <link>/api/reference/2880286</link>
          <label>79. , DOI: 10.1016/S0140-6736(18)31116-4</label>
          <listPosition>79</listPosition>
          <doi>10.1016/S0140-6736(18)31116-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880287</mtid>
          <link>/api/reference/2880287</link>
          <label>80. , DOI: 10.1001/jama.2019.9055</label>
          <listPosition>80</listPosition>
          <doi>10.1001/jama.2019.9055</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880288</mtid>
          <link>/api/reference/2880288</link>
          <label>81. , DOI: 10.1136/annrheumdis-2012-201324</label>
          <listPosition>81</listPosition>
          <doi>10.1136/annrheumdis-2012-201324</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880289</mtid>
          <link>/api/reference/2880289</link>
          <label>82. González-Vacarezza 2014: Rituximab and tocilizumab for the treatment of rheumatoid arthritis, Int J Technol Assess Health Care, 30, p. 282, DOI: 10.1017/S0266462314000221</label>
          <listPosition>82</listPosition>
          <doi>10.1017/S0266462314000221</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880290</mtid>
          <link>/api/reference/2880290</link>
          <label>83. , DOI: 10.1001/jama.2016.13512</label>
          <listPosition>83</listPosition>
          <doi>10.1001/jama.2016.13512</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880291</mtid>
          <link>/api/reference/2880291</link>
          <label>84. , DOI: 10.1136/bmj.l67</label>
          <listPosition>84</listPosition>
          <doi>10.1136/bmj.l67</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880292</mtid>
          <link>/api/reference/2880292</link>
          <label>85. , DOI: 10.1002/art.30194</label>
          <listPosition>85</listPosition>
          <doi>10.1002/art.30194</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880293</mtid>
          <link>/api/reference/2880293</link>
          <label>86. Harrold 2015: Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry, Arthritis Res Ther, 17, p. 256, DOI: 10.1186/s13075-015-0776-1</label>
          <listPosition>86</listPosition>
          <doi>10.1186/s13075-015-0776-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880294</mtid>
          <link>/api/reference/2880294</link>
          <label>87. , DOI: 10.3899/jrheum.141043</label>
          <listPosition>87</listPosition>
          <doi>10.3899/jrheum.141043</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880295</mtid>
          <link>/api/reference/2880295</link>
          <label>88. , DOI: 10.1136/annrheumdis-2013-203936</label>
          <listPosition>88</listPosition>
          <doi>10.1136/annrheumdis-2013-203936</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880296</mtid>
          <link>/api/reference/2880296</link>
          <label>89. , DOI: 10.1186/s13075-016-1179-7</label>
          <listPosition>89</listPosition>
          <doi>10.1186/s13075-016-1179-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880297</mtid>
          <link>/api/reference/2880297</link>
          <label>90. Harrold 2018: Real-World comparative effectiveness of tocilizumab monotherapy vs. tumor necrosis factor inhibitors with methotrexate in patients with rheumatoid arthritis, Rheumatol Ther, 5, p. 507, DOI: 10.1007/s40744-018-0127-1</label>
          <listPosition>90</listPosition>
          <doi>10.1007/s40744-018-0127-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880298</mtid>
          <link>/api/reference/2880298</link>
          <label>91. , DOI: 10.1007/s10067-014-2711-2</label>
          <listPosition>91</listPosition>
          <doi>10.1007/s10067-014-2711-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880299</mtid>
          <link>/api/reference/2880299</link>
          <label>92. Huang 2019: Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials, Clin Rheumatol, 38, p. 2765, DOI: 10.1007/s10067-019-04595-1</label>
          <listPosition>92</listPosition>
          <doi>10.1007/s10067-019-04595-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880300</mtid>
          <link>/api/reference/2880300</link>
          <label>93. Kekow 2012: Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure, Biol Targets Ther, 6, p. 191, DOI: 10.2147/BTT.S32244</label>
          <listPosition>93</listPosition>
          <doi>10.2147/BTT.S32244</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880301</mtid>
          <link>/api/reference/2880301</link>
          <label>94. Kim 2014: Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach, Arch Pharm Res, 37, p. 662, DOI: 10.1007/s12272-014-0337-1</label>
          <listPosition>94</listPosition>
          <doi>10.1007/s12272-014-0337-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880302</mtid>
          <link>/api/reference/2880302</link>
          <label>95. Kremer 2016: A phase IIb study of ABT-494, a selective JAK-1 inhibitor, in patients with rheumatoid arthritis and an inadequate response to anti-tumor necrosis factor therapy, Arthritis &amp; Rheumatology, 68, p. 2867, DOI: 10.1002/art.39801</label>
          <listPosition>95</listPosition>
          <doi>10.1002/art.39801</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880303</mtid>
          <link>/api/reference/2880303</link>
          <label>96. , DOI: 10.1136/annrheumdis-2017-212845</label>
          <listPosition>96</listPosition>
          <doi>10.1136/annrheumdis-2017-212845</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880304</mtid>
          <link>/api/reference/2880304</link>
          <label>97. Lee 2016: Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri, Int J Rheum Dis, 19, p. 1103, DOI: 10.1111/1756-185X.12822</label>
          <listPosition>97</listPosition>
          <doi>10.1111/1756-185X.12822</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880305</mtid>
          <link>/api/reference/2880305</link>
          <label>98. , DOI: 10.3310/hta15140</label>
          <listPosition>98</listPosition>
          <doi>10.3310/hta15140</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880306</mtid>
          <link>/api/reference/2880306</link>
          <label>99. , DOI: 10.1136/annrheumdis-2016-210713</label>
          <listPosition>99</listPosition>
          <doi>10.1136/annrheumdis-2016-210713</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880307</mtid>
          <link>/api/reference/2880307</link>
          <label>100. Ogata 2018: A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: results of the 12-week double-blind period, Modern Rheumatology, 28, p. 76, DOI: 10.1080/14397595.2017.1332507</label>
          <listPosition>100</listPosition>
          <doi>10.1080/14397595.2017.1332507</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880308</mtid>
          <link>/api/reference/2880308</link>
          <label>101. , DOI: 10.1111/1756-185X.12845</label>
          <listPosition>101</listPosition>
          <doi>10.1111/1756-185X.12845</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880309</mtid>
          <link>/api/reference/2880309</link>
          <label>102. , DOI: 10.1136/ard.2008.099218</label>
          <listPosition>102</listPosition>
          <doi>10.1136/ard.2008.099218</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880310</mtid>
          <link>/api/reference/2880310</link>
          <label>103. Schiff M , Combe B , Dörner T , et al . Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study. RMD Open 2015;1:e000037. doi:10.1136/rmdopen-2014-000037, DOI: 10.1136/rmdopen-2014-000037</label>
          <listPosition>103</listPosition>
          <doi>10.1136/rmdopen-2014-000037</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880311</mtid>
          <link>/api/reference/2880311</link>
          <label>104. Singh JA , Hossain A , Tanjong Ghogomu E , et al . Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 2017;74.doi:10.1002/14651858.CD012591, DOI: 10.1002/14651858.CD012591</label>
          <listPosition>104</listPosition>
          <doi>10.1002/14651858.CD012591</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880312</mtid>
          <link>/api/reference/2880312</link>
          <label>105. , DOI: 10.1136/annrheumdis-2013-203435</label>
          <listPosition>105</listPosition>
          <doi>10.1136/annrheumdis-2013-203435</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880313</mtid>
          <link>/api/reference/2880313</link>
          <label>106. Smolen 2016: Head-To-Head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study, The Lancet, 388, p. 2763, DOI: 10.1016/S0140-6736(16)31651-8</label>
          <listPosition>106</listPosition>
          <doi>10.1016/S0140-6736(16)31651-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880314</mtid>
          <link>/api/reference/2880314</link>
          <label>107. Soliman 2012: Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? comparative analysis from the British Society for rheumatology biologics register, Arthritis Care Res, 64, p. 1108, DOI: 10.1002/acr.21663</label>
          <listPosition>107</listPosition>
          <doi>10.1002/acr.21663</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880315</mtid>
          <link>/api/reference/2880315</link>
          <label>108. , DOI: 10.1002/acr.22453</label>
          <listPosition>108</listPosition>
          <doi>10.1002/acr.22453</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880316</mtid>
          <link>/api/reference/2880316</link>
          <label>109. , DOI: 10.1002/art.33353</label>
          <listPosition>109</listPosition>
          <doi>10.1002/art.33353</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880317</mtid>
          <link>/api/reference/2880317</link>
          <label>110. Takahashi 2015: Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use, Rheumatol Int, 35, p. 1707, DOI: 10.1007/s00296-015-3283-4</label>
          <listPosition>110</listPosition>
          <doi>10.1007/s00296-015-3283-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880318</mtid>
          <link>/api/reference/2880318</link>
          <label>111. Takeuchi 2016: Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: results from a randomized phase II trial, Mod Rheumatol, 26, p. 15, DOI: 10.3109/14397595.2015.1074648</label>
          <listPosition>111</listPosition>
          <doi>10.3109/14397595.2015.1074648</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880319</mtid>
          <link>/api/reference/2880319</link>
          <label>112. Torrente-Segarra 2016: VARIAR study: assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist, Reumatol Clínica, 12, p. 319, DOI: 10.1016/j.reuma.2015.11.019</label>
          <listPosition>112</listPosition>
          <doi>10.1016/j.reuma.2015.11.019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880320</mtid>
          <link>/api/reference/2880320</link>
          <label>113. van Vollenhoven 2015: Safety and efficacy of Atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, Double‐Blind, Placebo‐Controlled pilot trial, Arthritis Rheumatol, 67, p. 2828, DOI: 10.1002/art.39262</label>
          <listPosition>113</listPosition>
          <doi>10.1002/art.39262</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880321</mtid>
          <link>/api/reference/2880321</link>
          <label>114. Vial 2017: FRI0234 choice of biologic therapy following rituximab: influencing factors in a French multicenter cohort of rheumatoid arthritis, Ann Rheum Dis, 76, p. 573.2</label>
          <listPosition>114</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880322</mtid>
          <link>/api/reference/2880322</link>
          <label>115. Vieira 2016: Tofacitinib versus biologic treatments in patients with active rheumatoid arthritis who have had an inadequate response to tumor necrosis factor inhibitors: results from a network meta-analysis, Clin Ther, 38, p. 2628, DOI: 10.1016/j.clinthera.2016.11.004</label>
          <listPosition>115</listPosition>
          <doi>10.1016/j.clinthera.2016.11.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880323</mtid>
          <link>/api/reference/2880323</link>
          <label>116. , DOI: 10.1136/annrheumdis-2013-204544</label>
          <listPosition>116</listPosition>
          <doi>10.1136/annrheumdis-2013-204544</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880324</mtid>
          <link>/api/reference/2880324</link>
          <label>117. , DOI: 10.1093/rheumatology/kev297</label>
          <listPosition>117</listPosition>
          <doi>10.1093/rheumatology/kev297</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880325</mtid>
          <link>/api/reference/2880325</link>
          <label>118. Wei 2017: Treatment persistence and clinical outcomes of tumor necrosis factor inhibitor cycling or switching to a new mechanism of action therapy: real-world observational study of rheumatoid arthritis patients in the United States with prior tumor necrosis factor inhibitor therapy, Adv Ther, 34, p. 1936, DOI: 10.1007/s12325-017-0578-8</label>
          <listPosition>118</listPosition>
          <doi>10.1007/s12325-017-0578-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880326</mtid>
          <link>/api/reference/2880326</link>
          <label>119. Weinblatt 2018: A Randomized Phase II b Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis, Arthritis Rheumatol, 70, p. 49, DOI: 10.1002/art.40323</label>
          <listPosition>119</listPosition>
          <doi>10.1002/art.40323</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880327</mtid>
          <link>/api/reference/2880327</link>
          <label>120. , DOI: 10.1136/annrheumdis-2019-eular.3083</label>
          <listPosition>120</listPosition>
          <doi>10.1136/annrheumdis-2019-eular.3083</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880328</mtid>
          <link>/api/reference/2880328</link>
          <label>121. Zhang 2018: Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients, Clin Rheumatol, 37, p. 199, DOI: 10.1007/s10067-017-3806-3</label>
          <listPosition>121</listPosition>
          <doi>10.1007/s10067-017-3806-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880329</mtid>
          <link>/api/reference/2880329</link>
          <label>122. , DOI: 10.1016/j.jbspin.2010.01.010</label>
          <listPosition>122</listPosition>
          <doi>10.1016/j.jbspin.2010.01.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880330</mtid>
          <link>/api/reference/2880330</link>
          <label>123. Allam 2018: The effect of Siwan therapy in management of patients with rheumatoid arthritis: a single blind randomized controlled trial, Biomed Res, 29, p. 1400, DOI: 10.4066/biomedicalresearch.29-17-2906</label>
          <listPosition>123</listPosition>
          <doi>10.4066/biomedicalresearch.29-17-2906</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880331</mtid>
          <link>/api/reference/2880331</link>
          <label>124. , DOI: 10.1007/s00296-013-2819-8</label>
          <listPosition>124</listPosition>
          <doi>10.1007/s00296-013-2819-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880332</mtid>
          <link>/api/reference/2880332</link>
          <label>125. Anvar 2018: Effectiveness of self-management program on arthritis symptoms among older women: a randomized controlled trial study, Health Care Women Int, 39, p. 1326, DOI: 10.1080/07399332.2018.1438438</label>
          <listPosition>125</listPosition>
          <doi>10.1080/07399332.2018.1438438</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880333</mtid>
          <link>/api/reference/2880333</link>
          <label>126. Baxter 2016: Walking is a feasible physical activity for people with rheumatoid arthritis: a feasibility randomized controlled trial, Musculoskeletal Care, 14, p. 47, DOI: 10.1002/msc.1112</label>
          <listPosition>126</listPosition>
          <doi>10.1002/msc.1112</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880334</mtid>
          <link>/api/reference/2880334</link>
          <label>127. Cameron M , Gagnier JJ , Chrubasik S . Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev 2011:CD002948., DOI: 10.1002/14651858.CD002948.pub2</label>
          <listPosition>127</listPosition>
          <doi>10.1002/14651858.CD002948.pub2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880335</mtid>
          <link>/api/reference/2880335</link>
          <label>128. Carandang 2016: Systematic review of educational interventions for rheumatoid arthritis, Am J Occup Ther, 70, p. 7006290020p1, DOI: 10.5014/ajot.2016.021386</label>
          <listPosition>128</listPosition>
          <doi>10.5014/ajot.2016.021386</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880336</mtid>
          <link>/api/reference/2880336</link>
          <label>129. , DOI: 10.2522/ptj.20070039</label>
          <listPosition>129</listPosition>
          <doi>10.2522/ptj.20070039</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880337</mtid>
          <link>/api/reference/2880337</link>
          <label>130. de Thurah A , Esbensen BA , Roelsgaard IK , et al . Efficacy of embedded nurse-led versus conventional physician-led follow-up in rheumatoid arthritis: a systematic review and meta-analysis. RMD Open 2017;3:e000481. doi:10.1136/rmdopen-2017-000481, DOI: 10.1136/rmdopen-2017-000481</label>
          <listPosition>130</listPosition>
          <doi>10.1136/rmdopen-2017-000481</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880338</mtid>
          <link>/api/reference/2880338</link>
          <label>131. de Thurah 2018: Tele-Health followup strategy for tight control of disease activity in rheumatoid arthritis: results of a randomized controlled trial, Arthritis Care Res, 70, p. 353, DOI: 10.1002/acr.23280</label>
          <listPosition>131</listPosition>
          <doi>10.1002/acr.23280</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880339</mtid>
          <link>/api/reference/2880339</link>
          <label>132. DiRenzo D , Crespo-Bosque M , Gould N , et al . Systematic review and meta-analysis: Mindfulness-Based interventions for rheumatoid arthritis. Curr Rheumatol Rep 2018;20:75. doi:10.1007/s11926-018-0787-4, DOI: 10.1007/s11926-018-0787-4</label>
          <listPosition>132</listPosition>
          <doi>10.1007/s11926-018-0787-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880340</mtid>
          <link>/api/reference/2880340</link>
          <label>133. , DOI: 10.1111/j.1756-185X.2010.01563.x</label>
          <listPosition>133</listPosition>
          <doi>10.1111/j.1756-185X.2010.01563.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880341</mtid>
          <link>/api/reference/2880341</link>
          <label>134. , DOI: 10.1037/0278-6133.26.3.241</label>
          <listPosition>134</listPosition>
          <doi>10.1037/0278-6133.26.3.241</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880342</mtid>
          <link>/api/reference/2880342</link>
          <label>135. El Miedany 2012: Arthritis education: the integration of patient-reported outcome measures and patient self-management, Clin Exp Rheumatol, 30, p. 899</label>
          <listPosition>135</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880343</mtid>
          <link>/api/reference/2880343</link>
          <label>136. Eversden L , Maggs F , Nightingale P , et al . A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis. BMC Musculoskelet Disord 2007;8:23. doi:10.1186/1471-2474-8-23, DOI: 10.1186/1471-2474-8-23</label>
          <listPosition>136</listPosition>
          <doi>10.1186/1471-2474-8-23</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880344</mtid>
          <link>/api/reference/2880344</link>
          <label>137. , DOI: 10.1016/j.apmr.2015.09.022</label>
          <listPosition>137</listPosition>
          <doi>10.1016/j.apmr.2015.09.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880345</mtid>
          <link>/api/reference/2880345</link>
          <label>138. Ferwerda 2017: A tailored-guided Internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care, Pain, 158, p. 868, DOI: 10.1097/j.pain.0000000000000845</label>
          <listPosition>138</listPosition>
          <doi>10.1097/j.pain.0000000000000845</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880346</mtid>
          <link>/api/reference/2880346</link>
          <label>139. Fidahic M , Jelicic Kadic A , Radic M , et al . Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2017;15.doi:10.1002/14651858.CD012095.pub2, DOI: 10.1002/14651858.CD012095.pub2</label>
          <listPosition>139</listPosition>
          <doi>10.1002/14651858.CD012095.pub2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880347</mtid>
          <link>/api/reference/2880347</link>
          <label>140. Figen 2011: Long-Term effects of comprehensive inpatient rehabilitation on function and disease activity in patients with chronic rheumatoid arthritis and ankylosing spondylitis, Turkish J Rheumatol, 26, p. 135, DOI: 10.5152/tjr.2011.020</label>
          <listPosition>140</listPosition>
          <doi>10.5152/tjr.2011.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880348</mtid>
          <link>/api/reference/2880348</link>
          <label>141. Fitzcharles 2016: Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials, Arthritis Care Res, 68, p. 681, DOI: 10.1002/acr.22727</label>
          <listPosition>141</listPosition>
          <doi>10.1002/acr.22727</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880349</mtid>
          <link>/api/reference/2880349</link>
          <label>142. Gizińska 2015: Effects of whole-body cryotherapy in comparison with other physical modalities used with Kinesitherapy in rheumatoid arthritis, Biomed Res Int, 2015, p. 1, DOI: 10.1155/2015/409174</label>
          <listPosition>142</listPosition>
          <doi>10.1155/2015/409174</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880350</mtid>
          <link>/api/reference/2880350</link>
          <label>143. Gok Metin 2016: The effects of Aromatherapy massage and reflexology on pain and fatigue in patients with rheumatoid arthritis: a randomized controlled trial, Pain Management Nursing, 17, p. 140, DOI: 10.1016/j.pmn.2016.01.004</label>
          <listPosition>143</listPosition>
          <doi>10.1016/j.pmn.2016.01.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880351</mtid>
          <link>/api/reference/2880351</link>
          <label>144. , DOI: 10.1136/ard.2002.001511</label>
          <listPosition>144</listPosition>
          <doi>10.1136/ard.2002.001511</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880352</mtid>
          <link>/api/reference/2880352</link>
          <label>145. , DOI: 10.1136/bmj.38265.493773.8F</label>
          <listPosition>145</listPosition>
          <doi>10.1136/bmj.38265.493773.8F</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880353</mtid>
          <link>/api/reference/2880353</link>
          <label>146. , DOI: 10.3310/hta23010</label>
          <listPosition>146</listPosition>
          <doi>10.3310/hta23010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880354</mtid>
          <link>/api/reference/2880354</link>
          <label>147. Hurkmans 2009: Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis, Cochrane Database Syst Rev, 2009, p. CD006853</label>
          <listPosition>147</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880355</mtid>
          <link>/api/reference/2880355</link>
          <label>148. , DOI: 10.1136/ard.2010.129270</label>
          <listPosition>148</listPosition>
          <doi>10.1136/ard.2010.129270</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880356</mtid>
          <link>/api/reference/2880356</link>
          <label>149. Jastrząbek 2013: Effects of different local cryotherapies on systemic levels of TNF-α, IL-6, and clinical parameters in active rheumatoid arthritis, Rheumatol Int, 33, p. 2053, DOI: 10.1007/s00296-013-2692-5</label>
          <listPosition>149</listPosition>
          <doi>10.1007/s00296-013-2692-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880357</mtid>
          <link>/api/reference/2880357</link>
          <label>150. Jiang 2018: Influence of acupotomy loosing on IL-6, IL-10 and TNF-α in synovial fluid of rheumatoid arthritis patients with elbow joint stiffness, World J Acupunct - Moxibustion, 28, p. 91, DOI: 10.1016/j.wjam.2018.06.010</label>
          <listPosition>150</listPosition>
          <doi>10.1016/j.wjam.2018.06.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880358</mtid>
          <link>/api/reference/2880358</link>
          <label>151. , DOI: 10.1177/0091270009355813</label>
          <listPosition>151</listPosition>
          <doi>10.1177/0091270009355813</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880359</mtid>
          <link>/api/reference/2880359</link>
          <label>152. Knittle 2015: Targeting motivation and self-regulation to increase physical activity among patients with rheumatoid arthritis: a randomised controlled trial, Clin Rheumatol, 34, p. 231, DOI: 10.1007/s10067-013-2425-x</label>
          <listPosition>152</listPosition>
          <doi>10.1007/s10067-013-2425-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880360</mtid>
          <link>/api/reference/2880360</link>
          <label>153. Lau 2019: A brief report on the clinical trial on neural mobilization exercise for joint pain in patients with rheumatoid arthritis, Z Rheumatol, 78, p. 474, DOI: 10.1007/s00393-018-0521-7</label>
          <listPosition>153</listPosition>
          <doi>10.1007/s00393-018-0521-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880361</mtid>
          <link>/api/reference/2880361</link>
          <label>154. , DOI: 10.1093/rheumatology/kem151</label>
          <listPosition>154</listPosition>
          <doi>10.1093/rheumatology/kem151</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880362</mtid>
          <link>/api/reference/2880362</link>
          <label>155. Lee JA , Son MJ , Choi J , et al . Bee venom acupuncture for rheumatoid arthritis: a systematic review of randomised clinical trials. BMJ Open 2014;4:e006140. doi:10.1136/bmjopen-2014-006140, DOI: 10.1136/bmjopen-2014-006140</label>
          <listPosition>155</listPosition>
          <doi>10.1136/bmjopen-2014-006140</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880363</mtid>
          <link>/api/reference/2880363</link>
          <label>156. , DOI: 10.3899/jrheum.150550</label>
          <listPosition>156</listPosition>
          <doi>10.3899/jrheum.150550</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880364</mtid>
          <link>/api/reference/2880364</link>
          <label>157. , DOI: 10.1002/art.24563</label>
          <listPosition>157</listPosition>
          <doi>10.1002/art.24563</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880365</mtid>
          <link>/api/reference/2880365</link>
          <label>158. , DOI: 10.1093/rheumatology/kes133</label>
          <listPosition>158</listPosition>
          <doi>10.1093/rheumatology/kes133</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880366</mtid>
          <link>/api/reference/2880366</link>
          <label>159. , DOI: 10.1002/acr.22102</label>
          <listPosition>159</listPosition>
          <doi>10.1002/acr.22102</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880367</mtid>
          <link>/api/reference/2880367</link>
          <label>160. Mollard E , Michaud K . A mobile APP with optical imaging for the self-management of hand rheumatoid arthritis: pilot study. JMIR Mhealth Uhealth 2018;6:e12221. doi:10.2196/12221, DOI: 10.2196/12221</label>
          <listPosition>160</listPosition>
          <doi>10.2196/12221</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880368</mtid>
          <link>/api/reference/2880368</link>
          <label>161. Muñoz-Fernández 2016: Evaluation of the impact of nursing clinics in the rheumatology services, Rheumatol Int, 36, p. 1309, DOI: 10.1007/s00296-016-3518-z</label>
          <listPosition>161</listPosition>
          <doi>10.1007/s00296-016-3518-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880369</mtid>
          <link>/api/reference/2880369</link>
          <label>162. Prothero 2018: The evidence base for psychological interventions for rheumatoid arthritis: a systematic review of reviews, Int J Nurs Stud, 82, p. 20, DOI: 10.1016/j.ijnurstu.2018.03.008</label>
          <listPosition>162</listPosition>
          <doi>10.1016/j.ijnurstu.2018.03.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880370</mtid>
          <link>/api/reference/2880370</link>
          <label>163. Richards BL , Whittle SL , Buchbinder R . Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2011., DOI: 10.1002/14651858.CD008920.pub2</label>
          <listPosition>163</listPosition>
          <doi>10.1002/14651858.CD008920.pub2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880371</mtid>
          <link>/api/reference/2880371</link>
          <label>164. Santos 2016: Balneotherapy and rheumatoid arthritis: a randomized control trial, Isr Med Assoc J, 18, p. 474</label>
          <listPosition>164</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880372</mtid>
          <link>/api/reference/2880372</link>
          <label>165. Santos 2019: Effectiveness of non-pharmacological and non-surgical interventions for rheumatoid arthritis, JBI database Syst Rev Implement reports, 17, p. 1494, DOI: 10.11124/JBISRIR-D-18-00020</label>
          <listPosition>165</listPosition>
          <doi>10.11124/JBISRIR-D-18-00020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880373</mtid>
          <link>/api/reference/2880373</link>
          <label>166. Siqueira 2017: Effectiveness of aquatic exercises in women with rheumatoid arthritis: a randomized, controlled, 16-Week Intervention-The Hydra trial, Am J Phys Med Rehabil, 96, p. 167, DOI: 10.1097/PHM.0000000000000564</label>
          <listPosition>166</listPosition>
          <doi>10.1097/PHM.0000000000000564</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880374</mtid>
          <link>/api/reference/2880374</link>
          <label>167. Srikesavan 2019: Web-Based rehabilitation interventions for people with rheumatoid arthritis: a systematic review, J Telemed Telecare, 25, p. 263, DOI: 10.1177/1357633X18768400</label>
          <listPosition>167</listPosition>
          <doi>10.1177/1357633X18768400</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880375</mtid>
          <link>/api/reference/2880375</link>
          <label>168. , DOI: 10.1002/art.10665</label>
          <listPosition>168</listPosition>
          <doi>10.1002/art.10665</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880376</mtid>
          <link>/api/reference/2880376</link>
          <label>169. Wang 2017: Patient satisfaction after nurse-led care in Chinese patients with rheumatoid arthritis: a China study, Biomed Res, 28, p. 4972</label>
          <listPosition>169</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880377</mtid>
          <link>/api/reference/2880377</link>
          <label>170. Whittle SL , Richards BL , Husni E , et al . Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 2011;23.doi:10.1002/14651858.CD003113.pub3, DOI: 10.1002/14651858.CD003113.pub3</label>
          <listPosition>170</listPosition>
          <doi>10.1002/14651858.CD003113.pub3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880378</mtid>
          <link>/api/reference/2880378</link>
          <label>171. Williams MA , Srikesavan C , Heine PJ , et al . Exercise for rheumatoid arthritis of the hand. Cochrane Database Syst Rev 2018;32.doi:10.1002/14651858.CD003832.pub3, DOI: 10.1002/14651858.CD003832.pub3</label>
          <listPosition>171</listPosition>
          <doi>10.1002/14651858.CD003832.pub3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880379</mtid>
          <link>/api/reference/2880379</link>
          <label>172. Barton 2018: Experience and context shape patient and clinician goals for treatment of rheumatoid arthritis: a qualitative study, Arthritis Care Res, 70, p. 1614, DOI: 10.1002/acr.23541</label>
          <listPosition>172</listPosition>
          <doi>10.1002/acr.23541</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880380</mtid>
          <link>/api/reference/2880380</link>
          <label>173. Gibofsky A , Galloway J , Kekow J , et al . Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys. Health Qual Life Outcomes 2018;16:211. doi:10.1186/s12955-018-1035-3, DOI: 10.1186/s12955-018-1035-3</label>
          <listPosition>173</listPosition>
          <doi>10.1186/s12955-018-1035-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880381</mtid>
          <link>/api/reference/2880381</link>
          <label>174. Torikai 2018: AB0222 differences of disease impression and treatment expectation in rheumatoid arthritis patients with different disease activity, Ann Rheum Dis, 77, p. 1295</label>
          <listPosition>174</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880382</mtid>
          <link>/api/reference/2880382</link>
          <label>175. Fraenkel 2012: Decision tool to improve the quality of care in rheumatoid arthritis, Arthritis Care Res, 64, p. 977</label>
          <listPosition>175</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880383</mtid>
          <link>/api/reference/2880383</link>
          <label>176. Fraenkel 2015: Use of decision support for improved knowledge, values clarification, and informed choice in patients with rheumatoid arthritis, Arthritis Care Res, 67, p. 1496, DOI: 10.1002/acr.22659</label>
          <listPosition>176</listPosition>
          <doi>10.1002/acr.22659</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880384</mtid>
          <link>/api/reference/2880384</link>
          <label>177. LC 2014: Proof-Of-Concept study of a web-based methotrexate decision aid for patients with rheumatoid arthritis, Arthritis Care Res, 66, p. 1472, DOI: 10.1002/acr.22319</label>
          <listPosition>177</listPosition>
          <doi>10.1002/acr.22319</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880385</mtid>
          <link>/api/reference/2880385</link>
          <label>178. LC 2018: Effects of a web-based patient decision aid on biologic and small-molecule agents for rheumatoid arthritis: results from a proof-of-concept study, Arthritis Care Res, 70, p. 343, DOI: 10.1002/acr.23287</label>
          <listPosition>178</listPosition>
          <doi>10.1002/acr.23287</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880386</mtid>
          <link>/api/reference/2880386</link>
          <label>179. , DOI: 10.1093/rheumatology/ket374</label>
          <listPosition>179</listPosition>
          <doi>10.1093/rheumatology/ket374</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880387</mtid>
          <link>/api/reference/2880387</link>
          <label>180. Palmer 2010: Self-helplessness in arthritis: an important but overlooked index, Br J Nurs, 19, p. 965, DOI: 10.12968/bjon.2010.19.15.77692</label>
          <listPosition>180</listPosition>
          <doi>10.12968/bjon.2010.19.15.77692</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880388</mtid>
          <link>/api/reference/2880388</link>
          <label>181. Silvers 1985: Assessing physician/patient perceptions in rheumatoid arthritis. A vital component in patient education, Arthritis Rheum, 28, p. 300, DOI: 10.1002/art.1780280310</label>
          <listPosition>181</listPosition>
          <doi>10.1002/art.1780280310</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880389</mtid>
          <link>/api/reference/2880389</link>
          <label>182. , DOI: 10.1177/1073191103258144</label>
          <listPosition>182</listPosition>
          <doi>10.1177/1073191103258144</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880390</mtid>
          <link>/api/reference/2880390</link>
          <label>183. , DOI: 10.1093/rheumatology/37.4.373</label>
          <listPosition>183</listPosition>
          <doi>10.1093/rheumatology/37.4.373</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880391</mtid>
          <link>/api/reference/2880391</link>
          <label>184. , DOI: 10.1016/j.semarthrit.2010.04.001</label>
          <listPosition>184</listPosition>
          <doi>10.1016/j.semarthrit.2010.04.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880392</mtid>
          <link>/api/reference/2880392</link>
          <label>185. Bell 1998: A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis, J Rheumatol, 25, p. 231</label>
          <listPosition>185</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880393</mtid>
          <link>/api/reference/2880393</link>
          <label>186. , DOI: 10.2522/ptj.20090010</label>
          <listPosition>186</listPosition>
          <doi>10.2522/ptj.20090010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880394</mtid>
          <link>/api/reference/2880394</link>
          <label>187. , DOI: 10.1136/ard.2010.144691</label>
          <listPosition>187</listPosition>
          <doi>10.1136/ard.2010.144691</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880395</mtid>
          <link>/api/reference/2880395</link>
          <label>188. Hosseini Moghadam 2018: The effect of educational program on self-efficacy of women with rheumatoid arthritis: a randomized controlled clinical trial, Int J community based Nurs midwifery, 6, p. 12</label>
          <listPosition>188</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880396</mtid>
          <link>/api/reference/2880396</link>
          <label>189. Lineker 2001: Improvements following short term home based physical therapy are maintained at one year in people with moderate to severe rheumatoid arthritis, J Rheumatol, 28, p. 165</label>
          <listPosition>189</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880397</mtid>
          <link>/api/reference/2880397</link>
          <label>190. , DOI: 10.1002/art.23817</label>
          <listPosition>190</listPosition>
          <doi>10.1002/art.23817</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880398</mtid>
          <link>/api/reference/2880398</link>
          <label>191. , DOI: 10.1016/j.pec.2010.02.014</label>
          <listPosition>191</listPosition>
          <doi>10.1016/j.pec.2010.02.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880399</mtid>
          <link>/api/reference/2880399</link>
          <label>192. , DOI: 10.3109/11038128.2011.611820</label>
          <listPosition>192</listPosition>
          <doi>10.3109/11038128.2011.611820</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880400</mtid>
          <link>/api/reference/2880400</link>
          <label>193. , DOI: 10.1002/art.1790100405</label>
          <listPosition>193</listPosition>
          <doi>10.1002/art.1790100405</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880401</mtid>
          <link>/api/reference/2880401</link>
          <label>194. Roth 2009: The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study, Prim Care Companion J Clin Psychiatry, 11, p. 292, DOI: 10.4088/PCC.08m00749bro</label>
          <listPosition>194</listPosition>
          <doi>10.4088/PCC.08m00749bro</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880402</mtid>
          <link>/api/reference/2880402</link>
          <label>195. , DOI: 10.1016/j.pec.2003.08.001</label>
          <listPosition>195</listPosition>
          <doi>10.1016/j.pec.2003.08.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880403</mtid>
          <link>/api/reference/2880403</link>
          <label>196. Tuntland 2010: The Cochrane review of assistive technology for rheumatoid arthritis, Eur J Phys Rehabil Med, 46, p. 261</label>
          <listPosition>196</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880404</mtid>
          <link>/api/reference/2880404</link>
          <label>197. Lorig 1989: Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis, Arthritis Care Res., 32, p. 37, DOI: 10.1002/anr.1780320107</label>
          <listPosition>197</listPosition>
          <doi>10.1002/anr.1780320107</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880405</mtid>
          <link>/api/reference/2880405</link>
          <label>198. Kerschbaumer A , Sepriano A , Smolen JS , et al . Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research Informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2020:annrheumdis-2019-216656. doi:10.1136/annrheumdis-2019-216656, DOI: 10.1136/annrheumdis-2019-216656</label>
          <listPosition>198</listPosition>
          <doi>10.1136/annrheumdis-2019-216656</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>2880406</mtid>
          <link>/api/reference/2880406</link>
          <label>199. Nagy G , Roodenrijs NMT , Welsing PMJ . EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. Manuscript in preparation.</label>
          <listPosition>199</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/31802391</link>
      <label>Roodenrijs Nadia M et al. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. (2021) RMD OPEN 2056-5933 2056-5933 7 1</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; &gt; Roodenrijs, Nadia M T ✉ &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10057639&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10057639&quot; target=&quot;_blank&quot;&gt;Hamar, Attila&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10094727&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10094727&quot; target=&quot;_blank&quot;&gt;Kedves, Melinda&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10025749&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10025749&quot; target=&quot;_blank&quot;&gt;Nagy, György&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; van Laar, Jacob M &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; van der Heijde, Désirée &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Welsing, Paco M J &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;31802391&quot; mtid=&quot;31802391&quot; target=&quot;_blank&quot;&gt;Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;RMD OPEN&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;7&lt;/span&gt; : &lt;span class=&quot;journal-issue&quot;&gt;1&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: e001512 , 20 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2021)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1136/rmdopen-2020-001512&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1136/rmdopen-2020-001512&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;000606022300001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/000606022300001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85099202959&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85099202959&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;33419871&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=33419871&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_NONE&quot; title=&quot; Nincs &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512&quot; target=&quot;_blank&quot; href=&quot;https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:31802391 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-APPROVED&quot;&gt; Nyilvános &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Összefoglaló cikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 100&lt;/span&gt; | Független: 93 | Függő: 7 | Nem jelölt: 0 | WoS jelölt: 83 | Scopus jelölt:&amp;nbsp;86 | WoS/Scopus jelölt:&amp;nbsp;98 | DOI jelölt:&amp;nbsp;95 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt;
&lt;div class=&quot;authors&quot;&gt;
	&lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt;
	&lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt;

		&lt;div class=&quot;autype autype0&quot;&gt;				&lt;span class=&quot;author-name&quot; &gt;Roodenrijs Nadia M T ✉
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10057639&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10057639&quot; target=&quot;_blank&quot;&gt;Hamar Attila
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Hamar Attila&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; általános orvos&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Debreceni Egyetem&quot;&gt;DE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;ÁOK&lt;/span&gt;/&lt;span title=&quot;Belgyógyászati Intézet&quot;&gt;BelgyI&lt;/span&gt;/Reumatológiai Tanszék&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10094727&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10094727&quot; target=&quot;_blank&quot;&gt;Kedves Melinda
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Kedves Melinda&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Reumatológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10025749&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10025749&quot; target=&quot;_blank&quot;&gt;Nagy György
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Nagy György&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Immunológia&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Genetikai, Sejt- és Immunbiológiai Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Klinikum&quot;&gt;K&lt;/span&gt;/&lt;span title=&quot;Belgyógyászati és Onkológiai Klinika&quot;&gt;BOK&lt;/span&gt;/Reumatológiai és Klinikai Immunológiai Tanszék&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;van Laar Jacob M
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;van der Heijde Désirée
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Welsing Paco M J
    &lt;/span&gt;

				    &lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;31802391&quot; target=&quot;_blank&quot;&gt;Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;		&lt;span class=&quot;journal-title&quot;&gt;RMD OPEN&lt;/span&gt;

        &lt;span class=&quot;journal-issn&quot;&gt;(&lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2056-5933&quot;&gt;2056-5933&lt;/a&gt; &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2056-5933&quot;&gt;2056-5933&lt;/a&gt;)&lt;/span&gt;:
		&lt;span class=&quot;journal-volume&quot;&gt;7&lt;/span&gt; &lt;span class=&quot;journal-issue&quot;&gt;1&lt;/span&gt;
&lt;span class=&quot;page&quot;&gt;
		Paper e001512.
	 20 p. 
&lt;/span&gt;		 &lt;span class=&quot;year&quot;&gt;(2021)&lt;/span&gt;  
    &lt;/div&gt;
&lt;div class=&quot;pub-footer&quot;&gt;
    

	&lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv:
			Angol
		 |  &lt;/span&gt;

	&lt;span class=&quot;identifiers&quot;&gt;
						&lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot;	Gold
&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;10.1136/rmdopen-2020-001512&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1136/rmdopen-2020-001512&quot;&gt;
									DOI
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;000606022300001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/000606022300001&quot;&gt;
									WoS
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;85099202959&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85099202959&quot;&gt;
									Scopus
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;33419871&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=33419871&amp;dopt=Abstract&quot;&gt;
									PubMed
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_NONE&quot; title=&quot;	Nincs
&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512&quot; target=&quot;_blank&quot; href=&quot;https://rmdopen.bmj.com/lookup/doi/10.1136/rmdopen-2020-001512&quot;&gt;
									Egyéb URL
							&lt;/a&gt;
						&lt;/span&gt;
	&lt;/span&gt;


	&lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Rheumatology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Immunology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Immunology and Allergy&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt;
    &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt;


	&lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt;
		&lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 100&lt;/span&gt;
		| Független: 93
		| Függő: 7
		| Nem jelölt: 0
		| WoS jelölt: 83 
		|  Scopus jelölt:&amp;nbsp;86 
		|  WoS/Scopus jelölt:&amp;nbsp;98 
		|  DOI jelölt:&amp;nbsp;95 
		
	&lt;/div&gt;
    
    
	&lt;div class=&quot;publication-citation&quot;&gt;
		&lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;31802391&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt;
			Idézett közlemények száma: 3
		&lt;/a&gt;
	&lt;/div&gt;



    &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 31802391&lt;/span&gt;
    | &lt;span class=&quot;status-data status-APPROVED&quot;&gt; 	Nyilvános
  &lt;/span&gt;
        
	
	
Forrás	 Idéző
	
	
    | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk
			( Összefoglaló cikk
			
			)
		&lt;/span&gt;
      		| &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt;
	| &lt;span class=&quot;publication-sourceOfData&quot;&gt;kézi felvitel&lt;/span&gt;
&lt;/div&gt;


&lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2025.07.30. 10:20 Kósáné Holecz Anna Mária (SE_KK_Reumatológia_Admin5_KHAM, admin)
&lt;/div&gt;




	&lt;pre class=&quot;comment&quot; style=&quot;margin-top: 0; margin-bottom: 0;&quot;&gt;&lt;u&gt;Megjegyzés&lt;/u&gt;: Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands            
            Rheumatology, University of Debrecen, Debrecen, Hungary            
            Rheumatology, Bacs-Kiskun Megyei Korhaz, Kecskemet, Hungary            
            Genetics Cell- and Immunobiology and Rheumatology and Clinical Rheumatology, Semmelweis University, Budapest, Hunga...&lt;/pre&gt;
&lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
